PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31395901-0	2019	Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK.	YM 155	56-76	CREB regulated transcription coactivator 1	Mus musculus	108-114	
31597941-0	2019	Author Correction: Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK.	YM 155	75-95	CREB regulated transcription coactivator 1	Mus musculus	127-133	
31395901-0	2019	Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK.	YM 155	78-83	CREB regulated transcription coactivator 1	Mus musculus	108-114	
31395901-7	2019	Our data support that YM155 achieves this by blocking mTORC1 via the phosphorylation of Raptor at S792 through activated AMPKalpha (T172).	YM 155	22-27	CREB regulated transcription coactivator 1	Mus musculus	54-60	
31395901-9	2019	We provide the first evidence that YM155 functions as a potent activator of AMPKalpha, a robust suppressor of mTORC1 and an attenuator of global protein synthesis.	YM 155	35-40	CREB regulated transcription coactivator 1	Mus musculus	110-116